These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

324 related items for PubMed ID: 28691019

  • 1. Fish Oil Feeding Modulates the Expression of Hepatic MicroRNAs in a Western-Style Diet-Induced Nonalcoholic Fatty Liver Disease Rat Model.
    Wang H, Shao Y, Yuan F, Feng H, Li N, Zhang H, Wu C, Liu Z.
    Biomed Res Int; 2017; 2017():2503847. PubMed ID: 28691019
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Gan-Jiang-Ling-Zhu decoction alleviates hepatic steatosis in rats by the miR-138-5p/CPT1B axis.
    Dang Y, Xu J, Zhu M, Zhou W, Zhang L, Ji G.
    Biomed Pharmacother; 2020 Jul; 127():110127. PubMed ID: 32325349
    [Abstract] [Full Text] [Related]

  • 4. High-throughput sequencing reveals altered expression of hepatic microRNAs in nonalcoholic fatty liver disease-related fibrosis.
    Leti F, Malenica I, Doshi M, Courtright A, Van Keuren-Jensen K, Legendre C, Still CD, Gerhard GS, DiStefano JK.
    Transl Res; 2015 Sep; 166(3):304-14. PubMed ID: 26001595
    [Abstract] [Full Text] [Related]

  • 5. Chaihu Shugan powder influences nonalcoholic fatty liver disease in rats in remodeling microRNAome and decreasing fatty acid synthesis.
    Zheng C, Nie H, Pan M, Fan W, Pi D, Liang Z, Liu D, Wang F, Yang Q, Zhang Y.
    J Ethnopharmacol; 2024 Jan 10; 318(Pt A):116967. PubMed ID: 37506783
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Integrated analysis of hepatic mRNA and miRNA profiles identified molecular networks and potential biomarkers of NAFLD.
    Zhu M, Wang Q, Zhou W, Liu T, Yang L, Zheng P, Zhang L, Ji G.
    Sci Rep; 2018 May 16; 8(1):7628. PubMed ID: 29769539
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Identification and study of differentially expressed miRNAs in aged NAFLD rats based on high-throughput sequencing.
    Zhang Y, Xiang D, Hu X, Ruan Q, Wang L, Bao Z.
    Ann Hepatol; 2020 May 16; 19(3):302-312. PubMed ID: 31899128
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. A micro-RNA expression signature for human NAFLD progression.
    Guo Y, Xiong Y, Sheng Q, Zhao S, Wattacheril J, Flynn CR.
    J Gastroenterol; 2016 Oct 16; 51(10):1022-30. PubMed ID: 26874844
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Effect of miR-34a in regulating steatosis by targeting PPARα expression in nonalcoholic fatty liver disease.
    Ding J, Li M, Wan X, Jin X, Chen S, Yu C, Li Y.
    Sci Rep; 2015 Sep 02; 5():13729. PubMed ID: 26330104
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.